CD8A and fibrosis: Therefore, to assess CD8 T cell function following liver injury regression in the CCl4 model of advanced fibrosis, hepatotoxin administration was stopped in a randomized subgroup of mice after 12 weeks, and liver pathology was assessed 4 weeks later (Figure 3A).